Journal article · 2003

US FDA approves new class of HIV therapeutics

Debra Robertson

Nature Biotechnology, 21(5), 470–471 · Published 29 April 2003 · DOI 10.1038/nbt0503-470

View at the publisherCite this paper

In brief

“US FDA approves new class of HIV therapeutics” is a 2003 journal article by Debra Robertson, published in Nature Biotechnology. OpenAlex counts 59 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
59
Most cited in
2014 (4)
Authors
1

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Robertson, D. (2003). US FDA approves new class of HIV therapeutics. Nature Biotechnology, 21(5), 470–471. https://doi.org/10.1038/nbt0503-470

MLA 9

Robertson, Debra. “US FDA approves new class of HIV therapeutics.” Nature Biotechnology, vol. 21, no. 5, 2003, pp. 470–471. https://doi.org/10.1038/nbt0503-470.

Chicago

Robertson, Debra. 2003. “US FDA approves new class of HIV therapeutics.” Nature Biotechnology 21 (5): 470–471. https://doi.org/10.1038/nbt0503-470.

Harvard

Robertson, D. (2003) ‘US FDA approves new class of HIV therapeutics’, Nature Biotechnology, 21(5), pp. 470–471. doi:10.1038/nbt0503-470.

IEEE

D. Robertson, “US FDA approves new class of HIV therapeutics,” Nature Biotechnology, vol. 21, no. 5, pp. 470–471, 2003, doi: 10.1038/nbt0503-470.

BibTeX

@article{robertson2003approves,
  title     = {{US FDA approves new class of HIV therapeutics}},
  author    = {Robertson, Debra},
  journal   = {Nature Biotechnology},
  year      = {2003},
  volume    = {21},
  number    = {5},
  pages     = {470--471},
  doi       = {10.1038/nbt0503-470},
  url       = {https://doi.org/10.1038/nbt0503-470}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201322
201444
201533
201633
201722
201811
202011
202133
202211
202311

Topic and keywords

Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment

  • HIV treatment
  • FDA approval
  • antiretroviral drugs
  • drug approval

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Robertson, D. (2003). US FDA approves new class of HIV therapeutics. Nature Biotechnology, 21(5), 470–471. https://doi.org/10.1038/nbt0503-470

How many times has this paper been cited?

59 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Debra Robertson.

What is the DOI of this paper?

10.1038/nbt0503-470, permanently at https://doi.org/10.1038/nbt0503-470. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.